Literature DB >> 2803071

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus.

L B Krupp1, N G LaRocca, J Muir-Nash, A D Steinberg.   

Abstract

Fatigue is a prominent disabling symptom in a variety of medical and neurologic disorders. To facilitate research in this area, we developed a fatigue severity scale, subjected it to tests of internal consistency and validity, and used it to compare fatigue in two chronic conditions: systemic lupus erythematosus and multiple sclerosis. Administration of the fatigue severity scale to 25 patients with multiple sclerosis, 29 patients with systemic lupus erythematosus, and 20 healthy adults revealed that the fatigue severity scale was internally consistent, correlated well with visual analogue measures, clearly differentiated controls from patients, and could detect clinically predicted changes in fatigue over time. Fatigue had a greater deleterious impact on daily living in patients with multiple sclerosis and systemic lupus erythematosus compared with controls. The results further showed that fatigue was largely independent of self-reported depressive symptoms and that several characteristics could differentiate fatigue that accompanies multiple sclerosis from fatigue that accompanies systemic lupus erythematosus. This study demonstrates (1) the clinical and research applications of a scale that measures fatigue severity and (2) helps to identify features that distinguish fatigue between two chronic medical disorders.

Entities:  

Mesh:

Year:  1989        PMID: 2803071     DOI: 10.1001/archneur.1989.00520460115022

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  1337 in total

1.  Psychometric evaluation of the fatigue severity scale for use in chronic hepatitis C.

Authors:  L Kleinman; M W Zodet; Z Hakim; J Aledort; C Barker; K Chan; L Krupp; D Revicki
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

2.  Is fatigue in patients with multiple sclerosis related to autonomic dysfunction?

Authors:  L Keselbrener; S Akselrod; A Ahiron; M Eldar; Y Barak; Z Rotstein
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

3.  Health and socioeconomic status differences among antibody hepatitis C positive and negative transfusion recipients, 1986-1990.

Authors:  Robert S Hogg; Kevin J P Craib; David Pi; Samuel S Lee; Gerald Y Minuk; Colin M Shapiro; Martin T Schechter; Michael V O'Shaughnessy
Journal:  Can J Public Health       Date:  2003 Mar-Apr

Review 4.  Fatigue in multiple sclerosis: definition, pathophysiology and treatment.

Authors:  Lauren B Krupp
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

5.  Fatigue: a prevalent symptom in gastroparesis.

Authors:  Dinu Cherian; Susmita Paladugu; Murali Pathikonda; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2012-06-05       Impact factor: 3.199

Review 6.  Fatigue in primary biliary cirrhosis.

Authors:  Ghulam Abbas; Roberta A Jorgensen; Keith D Lindor
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-11       Impact factor: 46.802

7.  Pain, Fatigue, and Cognitive Symptoms Are Temporally Associated Within but Not Across Days in Multiple Sclerosis.

Authors:  Anna L Kratz; Susan L Murphy; Tiffany J Braley
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

Review 8.  Neuroimaging markers of chronic fatigue in older people: a narrative review.

Authors:  Davide Angioni; Kelly Virecoulon Giudici; Maria Montoya Martinez; Yves Rolland; Bruno Vellas; Philipe de Souto Barreto
Journal:  Aging Clin Exp Res       Date:  2020-07-30       Impact factor: 3.636

9.  A SIX-WEEK SUPERVISED EXERCISE AND EDUCATIONAL INTERVENTION AFTER TOTAL HIP ARTHROPLASTY: A CASE SERIES.

Authors:  Federico Pozzi; Kathleen Madara; Joseph A Zeni
Journal:  Int J Sports Phys Ther       Date:  2017-04

10.  Prevalence and predictors of depression in Iranian patients with multiple sclerosis: a population-based study.

Authors:  Seyed Mohammad Seyed Saadat; Mozaffar Hosseininezhad; Babak Bakhshayesh; Seyedeh Nastaran Seyed Saadat; Seyedeh Parand Nabizadeh
Journal:  Neurol Sci       Date:  2013-12-10       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.